EP Wealth Advisors LLC Has $307,000 Position in Monsanto Company (MON)
EP Wealth Advisors LLC boosted its holdings in Monsanto Company (NYSE:MON) by 0.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,593 shares of the basic materials company’s stock after purchasing an additional 1 shares during the period. EP Wealth Advisors LLC’s holdings in Monsanto were worth $307,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of MON. Pinnacle Financial Partners Inc. purchased a new position in Monsanto in the second quarter valued at about $114,000. Bruderman Asset Management LLC bought a new position in Monsanto during the 2nd quarter worth approximately $116,000. Tower Research Capital LLC TRC lifted its holdings in Monsanto by 230.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after buying an additional 750 shares during the last quarter. JNBA Financial Advisors lifted its holdings in Monsanto by 3.9% during the 1st quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after buying an additional 45 shares during the last quarter. Finally, Armbruster Capital Management Inc. lifted its holdings in Monsanto by 12.2% during the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after buying an additional 125 shares during the last quarter. 74.77% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company (NYSE MON) traded up 0.03% during mid-day trading on Monday, reaching $122.34. The company had a trading volume of 805,802 shares. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $122.80. The company’s 50 day moving average is $118.79 and its 200 day moving average is $117.33. The stock has a market capitalization of $53.77 billion, a price-to-earnings ratio of 24.04 and a beta of 1.07.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter in the prior year, the business earned $0.07 EPS. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. Equities analysts predict that Monsanto Company will post $5.71 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.77%. The ex-dividend date is Thursday, October 5th. Monsanto’s dividend payout ratio is 42.27%.
A number of research firms have commented on MON. UBS AG downgraded Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Wells Fargo & Company increased their target price on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a report on Tuesday, October 10th. Barclays PLC reaffirmed an “equal weight” rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Thursday, October 5th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $128.00 target price on shares of Monsanto in a report on Wednesday, August 2nd. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $124.61.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the company’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.00, for a total transaction of $343,200.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Brett D. Begemann sold 22,640 shares of the company’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.03, for a total value of $2,717,479.20. Following the transaction, the chief operating officer now directly owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 37,026 shares of company stock worth $4,440,341. Company insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.